SEC investigating Illumina over acquisition of cancer test developer Grail
A building on the campus at the world headquarters of Illumina is shown in San Diego, California, Sept. 1, 2021.Mike Blake | ReutersThe U.S. Securities and Exchange Commission is investigating Illumina over its controversial $7.1 billion…